Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of 68Ga-PSMA-11 PSMA PET/MRI in Selecting Patients With Prostate Cancer for Focal Therapy: A Pilot Study

NCT07747493 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT07747493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07747493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of 68Ga-PSMA-11 PSMA PET/MRI in Selecting Patients With Prostate Cancer for Focal Therapy: A Pilot Study
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 31, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized prostate cancer, prostate cancer (adenocarcinoma)